Karyopharm Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Karyopharm Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $31k | 21k | 1.51 |
| 2023-09-30 | $160k | 119k | 1.34 |
| 2023-06-30 | $136k | 76k | 1.79 |
| 2023-03-31 | $21k | 5.5k | 3.89 |
| 2022-12-31 | $769k | 226k | 3.40 |
| 2022-09-30 | $1.4M | 252k | 5.46 |
| 2022-06-30 | $1.3M | 299k | 4.51 |
| 2022-03-31 | $2.2M | 294k | 7.37 |
| 2021-12-31 | $1.3M | 200k | 6.43 |
| 2021-09-30 | $500k | 86k | 5.82 |
| 2021-06-30 | $1.2M | 121k | 10.32 |
| 2021-03-31 | $1.4M | 129k | 10.52 |
| 2020-12-31 | $1.6M | 102k | 15.48 |
| 2020-09-30 | $2.2M | 152k | 14.60 |
| 2020-06-30 | $2.2M | 117k | 18.94 |
| 2020-03-31 | $2.4M | 124k | 19.21 |
| 2019-12-31 | $4.7M | 247k | 19.17 |
| 2019-09-30 | $139k | 14k | 9.65 |
| 2019-06-30 | $27k | 4.5k | 6.00 |
| 2019-03-31 | $92k | 16k | 5.86 |
| 2018-12-31 | $51k | 5.4k | 9.44 |
| 2018-09-30 | $107k | 6.3k | 16.98 |
| 2018-06-30 | $117k | 6.9k | 16.96 |
| 2018-03-31 | $188k | 14k | 13.43 |
| 2017-12-31 | $416k | 43k | 9.61 |
| 2017-09-30 | $620k | 57k | 10.97 |
| 2017-06-30 | $413k | 46k | 9.06 |
| 2017-03-31 | $1.0M | 78k | 12.84 |
| 2016-12-31 | $145k | 15k | 9.42 |
| 2016-09-30 | $198k | 20k | 9.71 |
| 2016-06-30 | $21k | 3.1k | 6.77 |
| 2016-03-31 | $202k | 23k | 8.94 |
| 2015-12-31 | $242k | 18k | 13.22 |
| 2015-09-30 | $614k | 58k | 10.53 |
| 2015-06-30 | $5.0k | 200 | 25.00 |
| 2015-03-31 | $67k | 2.2k | 30.45 |
| 2014-12-31 | $7.0k | 200 | 35.00 |
| 2014-09-30 | $63k | 1.8k | 35.00 |
Top funds holding Karyopharm Therapeutics
View all funds holding Karyopharm Therapeutics